Thrombotic microangiopathies: Physiopathology, diagnosis, treatment;Microangiopathies thrombotiques: Physiopathologie, diagnostic et traitement

Reanimation

Volumn 14, Issue 7, 2005, Pages 594-603

  Coppo, P ^a   Veyradier, A ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Hemolysis; Hemolytic and uremic syndrome; Seizures; Thrombopenia; Thrombotic microangiopathy; Thrombotic thrombocytopenic purpura; Von Willebrand factor

Indexed keywords

PHOSPHOLIPID ANTIBODY; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME DEFICIENCY; GENE MUTATION; HELLP SYNDROME; HEMOLYTIC UREMIC SYNDROME; HEREDITARY HEMOLYTIC ANEMIA; HUMAN; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; THROMBOCYTOPENIA; THROMBOCYTOPENIC PURPURA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 29244462310     PISSN: 16240693     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reaurg.2005.10.008     Document Type: Short Survey

References (37)

1. M. Furlan, R. Robles, M. Galbusera, G. Remuzzi, P.A. Kyrle, and B. Brenner Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome N. Engl. J. Med. 339 1998 1578 1584
2. H.M. Tsaï, and E.-Y. Lian Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura N. Engl. J. Med. 339 1998 1585 1594
3. G.G. Levy, D.G. Motto, and D. Ginsburg ADAMTS13 Turns 3 Blood 106 2005 11 17
4. A. Veyradier, and D. Meyer Thrombotic thrombocytoṕnic purpura and its diagnosis J. Thromb. Haemost. 3 2005 2420 2427
5. J.L. Moake, C.K. Rudy, J.H. Troll, M.J. Weinstein, N.M. Colannine, and J. Azocar Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura N. Engl. J. Med. 307 1982 1432 1435
6. J.L. Moake, N.A. Turner, N.A. Stathopoulos, L.H. Nolasco, and J.D. Hellums Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation J. Clin. Invest. 78 1986 1456 1461
7. Coppo P, Vernant JP, Veyradier A, Frémeaux-Bacchi V, Mira JP, Guidet B, Azoulay E, Rondeau E, Bussel A, pour le Réseau d'Etude des Microangiopathies Thrombotiques de l'Adulte. Purpura thrombotique thrombocytopénique et autres syndromes de microangiopathie thrombotique. Encyclopédie Médico-Chirurgicale (Hématologie) 2005:; 13-020-D-10:: 1-15.
8. A. Veyradier, B. Obert, A. Houllier, D. Meyer, and J.P. Girma Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases Blood 98 2001 1765 1772
9. P.M. Mannucci, M.T. Canciani, I. Forza, F. Lussana, A. Lattuada, and E. Rossi Changes in health and disease of the metalloprotease that cleaves von Willebrand factor Blood 98 2001 2730 2735
10. P. Coppo, D. Bengoufa, A. Veyradier, M. Wolf, A. Bussel, and G.A. Millot for the ŕseau d' etude des microangiopathies thrombotiques de l'adulte. Severe ADAMTS13 deficiency in adult Idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count and mild renal involvement Medicine (Baltimore) 83 2004 1 12
11. F. Scheiflinger, P. Knobl, B. Trattner, B. Plaimauer, G. Mohr, and M. Dockal Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura Blood 102 2003 3241 3243
12. G.G. Levy, W.C. Nichols, E.C. Lian, T. Foroud, J.N. McClintick, and B.M. McGee Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura Nature 413 2001 488 494
13. A. Veyradier, J.M. Lavergne, A.S. Ribba, B. Obert, C. Loirat, and D. Meyer Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) J. Thromb. Haemost. 2 2004 424 429
14. S.K. Vesely, J.N. George, B. Lammle, J.D. Studt, L. Alberio, and M.A. El-Karake ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients Blood 102 2003 60 68
15. J.M. Korach, D. Petitpas, B. Paris, F. Bourgeade, V. Passerat, and P. Berger Plasma exchange in france: epidemiology 2001 Transf. Apher. Sci. 29 2003 153 157
16. E.L. Amorosi, and J.E. Ultmann Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature Medicine (Baltimore) 45 1966 139 159
17. R.L. Ridolfi, and W.R. Bell Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature Medicine (Baltimore) 60 1981 413 428
18. R. Schneppenheim, U. Budde, F. Oyen, D. Angerhaus, V. Aumann, and E. Drewke Von Willebrand factor cleaving protease and ADAMTS13 mutations in childwood TTP Blood 101 2003 1845 1850
19. M. Rose, and A. Eldor High incidence of relapses in thrombotic thrombocytopenic purpura. Clinical study of 38 patients Am. J. Med. 83 1987 437 444
20. G.A. Rock, K.H. Shumak, N.A. Buskard, V.S. Blanchette, J.G. Kelton, and R.C. Nair Canadian Apheresis Group. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura N. Engl. J. Med. 325 1991 393 397
21. J.F. Patton, K.R. Manning, D. Case, and J. Owen Serum lactate deshydrogenase and platelet count predict survival in thrombotic thrombocytopenic purpura Am. J. Hematol. 47 1994 94 99
22. X.L. Zheng, R.M. Kaufman, L.T. Goodnough, and J.E. Sadler Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and non-idiopathic thrombotic thrombocytopenic purpura Blood 103 2004 4043 4049
23. P. Coppo, M. Wolf, A. Veyradier, A. Bussel, S. Malot, G.A. Millot, C. Daubin, D. Bordessoule, F. P̀ne, J.P. Mira, F. Heshmati, E. Maury, B. Guidet, E. Boulanger, L. Galicier, N. Parquet, J.P. Vernant, E. Rondeau, E. Azoulay, and B. Schlemmer Ŕseau d'́tude des microangiopathies thrombotiques de l'adulte. Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult acquired thrombotic thrombocytopenic purpura Br. J. Haematol. 2005 sous presse
24. W.R. Bell, H.G. Braine, P.M. Ness, and T.S. Kichler Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients N. Engl. J. Med. 325 1991 398 403
25. P. Coppo, A. Bussel, S. Charrier, C. Adrie, C. Alberti, and J.R. Le Gall Early high dose plasma infusion vs plasmapheresis as an emergency treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome Medicine (Baltimore) 82 2003 27 38
26. I. Tostivint, B. Mougenot, A. Flahault, C. Vigneau, M.A. Costa, and J.P. Haymann Adult haemolytic and uraemic syndrome: causes and prognostic factors in the last decade Nephrol. Dial. Transplant. 17 2002 1228 1234
27. M.A. Dragon-Durey, V. Fŕmeaux-Bacchi, C. Loirat, J. Blouin, P. Niaudet, and B. Deschenes Heterozygous and homozygous FH deficiencies associated with HUS or MPGN: Report and genetic analysis of 16 cases J. Am. Soc. Nephrol. 15 2004 787 795
28. V. Fremeaux-Bacchi, M.A. Dragon-Durey, J. Blouin, C. Vigneau, D. Kuypers, and B. Boudailliez Complement factor I: a susceptibility gene for atypical uraemic syndrome J. Med. Genet. 41 2004 e84
29. M. Noris, S. Brioschi, J. Caprioli, M. Todeschini, E. Bresin, and F. Porrati Familial haemolytic uraemic syndrome and an MCP mutation Lancet 362 2003 1542 1547
30. M.A. Dragon-Durey, C. Loirat, S. Cloarec, M.A. Macher, J. Blouin, and H. Nivet Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome J. Am. Soc. Nephrol. 16 2005 555 563
31. K. Mc Crae, and D. Cines Thrombotic microangiopathy during pregnancy Semin. Hematol. 34 1997 148 158
32. V. Roy, M.A. Rizvi, S.K. Vesely, and J.N. George Thrombotic- thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes Bone Marrow Transplant. 27 2001 641 646
33. A.J. Murgo Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents Semin. Hematol. 24 1987 161 177
34. C.L. Bennett, P.D. Weinberg, K. Rosenberg-Ben-Dror, P.R. Yarnold, H.C. Kwaan, and D. Green Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases Ann. Intern. Med. 128 1998 541 544
35. C.L. Bennett, J.M. Connors, J.M. Carwile, J.L. Moake, W.R. Bell, and S.R. Tarantolo Thrombotic thrombocytopenic purpura associated with clopidogrel N. Engl. J. Med. 342 2000 1773 1777
36. C. Masslo, M.N. Peraldi, J.C. Desenclos, B. Mougenot, C. Cywiner-Golenzer, and F.P. Chatelet Thrombotic microangiopathy and cytomegalovirus disease in patients infected with human immunodeficiency virus Clin. Infect. Dis. 24 1997 350 355
37. S. Becker, G. Fusco, J. Fusco, R. Balu, S. Gangju, and C. Brennan For the collaborations in HIV outcome Research/VS cohort. HIV-associated thrombotic microangiopathy in the era of highly active antiretroviral therapy: an observational study Clin. Infect. Dis. 39 Suppl 5 2004 S267 S275